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Introduction
South Africa has the second largest elderly population in Sub-
Saharan Africa1 with the population aged 60 years and older
projected to increase from 7.1% in 1996 to 8.4% in 2014.2
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Abstract
Objective: The aim of this study was to report on the prevalence of cognitive impairment, and to assess the performance and
utility of subjective, objective and informant screening tools in a heterogeneous community sample. Method: A sample of 302
elderly participants (>60 years) living in residential homes in a large city in South Africa were screened for the presence of
cognitive impairment using objective (Mini-Mental State Examination [MMSE] and Six Item Screener-[SIS]), subjective (Subjective
Memory Complaint [SMC]and Subjective Memory Rating Scale [SMRS]) and informant (Deterioration Cognitive Observee
[DECO]) screening tools. All tools were compared to the MMSE and the influence of demographic variables on the performance
on these tools was considered. Results: Significantly lower MMSE scores were found in participants aged 80-89 years (p=.023)
and those who had 8-11 years of education (p=.002). For every one additional year of education, participants were 0.71 times less
likely to screen positive on the MMSE. Differential item functioning on various components of the MMSE was demonstrated due
to the effects of education, race and gender. There was significant differential performance between the recommended and
alternate attention/concentration items (p<.001) with the alternate item favouring better performance. Based on the MMSE cut-
off score of < 23, the prevalence of cognitive impairment was 16.9%; the prevalence yielded by the remaining tools ranged from
10.5% using the DECO to 46% as determined by the presence of a SMC. Using the MMSE as the reference standard for the
presence of cognitive impairment, the SIS, SMC, SMRS and DECO had sensitivities of 82.3%, 54.6%, 17.0% and 37.5%, and
specificities of 71.3%, 57.6%, 87.4% and 96.7% respectively. Age and race influenced performance on the MMSE, SIS and SMRS.
Conclusion: Different types of cognitive screening tools yielded varying sensitivities and specificities for identifying cognitive
impairment when compared to the MMSE. The influence of race, age and education on test performance highlights the need for
suitable, culture-fair screening tools. Locally, the alternate item for attention/concentration should be preferred.
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However, the serious consequences of population ageing
do not appear to be planned for as evidenced by the lack of
a national dementia care policy. There is a lack of recent
data on morbidity as well as a paucity of research
particularly in the areas of cognitive, mental and physical
functioning of the elderly.3 Dementia, a condition largely
affecting the aged, requires specialised services, few of
which exist either in the public or private health sector in
South Africa. The projected increase in the prevalence of
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dementia, especially in lower and middle income
countries (LAMIC), and the resultant increase in demand
for services ‘needs to be met by adequately prepared and
resourced services…’.4 The Kyoto Declaration identified
the recognition and treatment of dementia at primary
health care level as a first priority.5 Recognition of
dementia requires the use of screening tools to identify
individuals who warrant intensive clinical diagnostic
evaluation. The validation of screening tools in the local
context is an important first step in this process. 
Dementia poses a significant health and economic
burden to society.6 It is the 11th leading cause of years
lived with disability (YLDs) at a global level, and accounts
for 2% of total YLDs.7 The annual cost of caring for people
with dementia in the UK and USA are $10 billion and $100
billion respectively.8 Economic models suggest that early
dementia diagnoses are more cost effective4 and that a
delay of progression from Mild Cognitive Impairment
(MCI) to Alzheimer’s Disease (AD), even by one year,
could have significant cost implications for health and
social services.9 Early diagnosis and intervention is
therefore recommended10 and actively promoted in high-
income countries (HIC)4, despite widespread routine
screening not being recommended by the United States
Preventive Services Task Force.11 MCI, an intermediate
stage between normal age-associated cognitive decline
and dementia, shows substantial variation in reported
prevalence, but may be present in up to 42% of elderly
populations.12 It is associated with disability and
neuropsychiatric symptoms.13 Together with dementia, it
therefore also requires early detection if any significant
impact is to be made on the burden posed by cognitive
impairment in the elderly. 
Screening initiatives are compounded by refusal rates
as high as 50%14, with a survey conducted in the USA and
Europe revealing low levels of acceptance by the elderly
and the perception that screening was harmful.15
Dementia screening enjoys a low priority in low and
middle income country (LAMIC) healthcare systems that
face considerable burdens relating to communicable
diseases.16,17 Fifty-eight percent of people with dementia
currently live in LAMIC and this figure will increase to 70%
in 2025 and to 71% by 2050.12 The treatment gap for
dementia is as high as 90%18 in these countries compared
to 20%-50% in HIC.19 Empirical data on dementia in
LAMICs is limited6, with a dearth of large community-
based epidemiological studies20 and only seven
methodologically robust studies being identified by the
10/66 Dementia Research Group in 2000.21
Due to existing resource constraints and competing
health priorities, a cost-effective strategy for dementia is
needed. Screening tools, largely the product of Western
psychological paradigms22, are ability assessments that
are not culture-fair23, and they therefore pose challenges
to being used among diverse cultural, ethnic, language
and literacy populations in LAMIC, as well as within and
between HIC.24,25 Screening tools need to be brief, easy to
administer, clinically acceptable, effective, minimally
affected by education, gender and ethnicity26, and have
sound psychometric properties. At the same time, it is
recommended that similar screening tools should be used
in LAMIC and HIC to facilitate comparisons between
studies, and that such tools should be reliable and
administrable by both paraprofessionals and trained non-
professionals.20
To date, few studies have been conducted in SA to
evaluate the performance of screening tools that are
commonly in use. The MMSE has been used in a
homogenous population as a diagnostic tool without
comment on its psychometric properties.27 In another study
involving ten patients, it was concluded that the MMSE was
an ‘out-dated and inadequate’ screening tool.28 The utility of
the DECO29 as an informant screening tool has been
assessed in a pilot study and found to be a sensitive
measure for mild and moderate dementia and its use
recommended, with minor modifications, in community
studies.30
The aims of this study were to calculate the prevalence
of cognitive impairment, evaluate the performance of the
Mini-Mental State Examination (MMSE)31, the Six Item
Screener (SIS)32, the presence of a subjective memory
complaint (SMC), Subjective Memory Rating Scale (SMRS)33
and the Deterioration Cognitive Observee scale (DECO) in
identifying cognitive impairment in a heterogeneous elderly
South African population. We also sought to establish the
degree to which race, age, education level and depression
may influence the performance of these screening tools. 
Method
Sites
This study was conducted in a group of retirement homes
administered by a non-governmental organisation (NGO) in
Durban, KwaZulu-Natal, South Africa between August and
October 2010. The residential facilities ranged from frail
care to independent living, and cater for all ethnic groups
and socio-economic classes, representing a cross-section of
the local elderly population. 
Sample
A sample of 302 was assessed to have adequate power to
provide caseness in screening. Inclusion criteria were:
residents who were 60 years and older, with a minimum of 8
years of formal schooling, the ability to speak, read and
write in English and the ability to give written, informed
consent. Exclusion criteria were residents with severe
physical, mental or sensory handicaps that precluded their
engagement in the assessment procedures. A random
sample was initially selected electronically from a database
of the 1371 residents. There was a high refusal rate and
many residents were not at home which resulted in a low
yield of participants. To address this, the approach was
revised to a door-to-door convenience sampling method
that included all residents who were available on the day of
screening and who agreed to participate. A total of 733
residents were screened of which 302 met the inclusion
criteria. Of the remaining 431 (58.8%), 155 failed to meet
the inclusion criteria, 227 declined and 49 were unavailable. 
Assessments
Screening assessments were conducted at the participants’
residences by a trained senior psychiatric registrar using
the MMSE, SMRS and the DECO. The Six Item Screener
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(SIS), comprising a subset of the MMSE items was also
analysed separately as it has the potential to substitute the
MMSE, especially in resource-constrained clinical
environments where lengthy administration time may be a
significant deterrent to regular screening. The SMRS was
administered to those participants who replied ‘yes’ to the
question: ‘Are you experiencing any difficulty with your
memory?’ The SMRS defines five specific contexts of
memory impairment with respect to duration (last 10-20
years) whereas the SMC documents the presence of
subjective awareness of memory problems in general. In
the MMSE, the terms for orientation to place were modified
to accommodate the local geographical context and two of
the three registration/recall items were substituted. The
DECO was administered to available informants who had
monthly contact with the study participants for at least two
years. Depression was identified using the Geriatric
Depression Scale (GDS)34 employing a cut-off score of >11.
The psychometric properties of the tests are reported in
Table I. 
Statistical analysis
The data for all tools were analysed using IBM® SPSS®19,
and the significance for all tests set at p<.05. Cognitive
impairment cases were classified using the identified cut-
off scores for ‘cases’ for each test as indicated in Table 1.
Sensitivity and specificity (95% Confidence Intervals (CIs))
of the SMRS, SMC, SIS and DECO were calculated against
the MMSE cognitive impairment ‘cases’. Numerical
variables were tested for normality using Kolmogorov-
Smirnov Z. Data were then compared for differences
between ‘cases’ and non-cases for cognitive impairment for
all tests using parametric-tests and non-parametric tests
(Chi-square or Fisher Exact Test (X2), Mann Whitney (U)
and Kruskall Wallis (K) tests),and for related samples the
Wilcoxon signed-rank test (W). Direct logistic regression
was performed to assess the impact of race, age and years
of education on the classification of cognitive impairments
as defined by MMSE ‘cases’. 
Ethics
The study received ethical approval from the Biomedical
Research Ethics Committee of the University of KwaZulu-
Natal. 
Results
Following an analysis of the participants’ race, age and
education levels, the results for each of the tools are
presented separately. 
Demographics
The age of the participants ranged from 60 to 94 years
(mean 73.5 ± 7.7) and the female to male ratio was 2.6.
More than half of the participants were white (168, 55.6%),
followed by coloureds (67, 22.2%), Asian (58, 19.2%) and 9
(3.0%) were black. The mean number of years of formal
education was 10.4 ± 2.2 years and ranged from a minimum
of eight years to a maximum of 19 years. Seventy per cent of
Table I: Psychometric properties of dementia screening tests
Domains measured Method of administration Sensitivity & Specificity Reliability Validity
MMSE31
11 items: Orientation, registration, attention/ Interviewer administered 85.1% & 85.5%35 Cronbach α = .54-9636 Content: Good: Concurrent:
concentration, calculation, recall, naming, 7-10 Minutes Interrater=.9 Correlates with WAIS31, 
repetition, comprehension, writing, construction. Cut-off score: 23/24 Test Retest =.80-.95 Reisberg Global Deterioration
Kendall Coefficients= .731 Scale & Blessed Dementia 
Scale37
SIS32
6 items Interviewer administered 88.7% & 88.0% Test-retest moderate Not available
3 item temporal orientation and 3 item recall 3 minutes (Kappa=.52) (Shah)
Cut-off score: 4/5
DECO29
Changes in behaviour noticed over 1 year in-activity Informant administered 79% & 90% Inter-rater =.87 Not available
level, semantic and visual memory, memory for 11-15 minutes Test Retest = .92
places, events and procedures, visuo-spatial Cut-off score: 24/25
performance and new skill learning  
SMRS33
Changes in remembering names, faces, friends, Self-administered 43.0% (pooled) & Cronbach α = .633 Face validity at 70,75,
appointments and judging the time 5 minutes 85.8%38 and 80, 
Cut-off score: 19/20 Hazard ratios: 6.0 (95% 
CI 52.1–18), 3.2 (95% 
CI 51.6–6.2) and 1.6 (95% 
CI 50.86–3.1)33
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participants had a high-school education and 8.9% had a
tertiary education. 
There was a significant association between race and
age (white 75.1 and Asian 70.9 years of age, K=15.8,
p=.001) and race and years of education (white 10.8 and
coloured 9.6, K=22.6, p<.001). Years of education was also
associated with gender (Male 10.7 and Females 10.3
years, U=1.0, p=.047). 
Mini Mental State Examination (MMSE) and Six Item
Screener (SIS)
The MMSE was administered to all 302 participants and
scored using both the recommended and the alternate
items for the assessment of attention/concentration
(Copyright restrictions preclude further description of
these items). Over half of the participants (184, 60.9%)
scored higher on the alternate item, 92 (30.5%) scored the
same and 26 (8.6%) lower. This resulted in a significantly
higher MMSE total using the alternate (mean 26.0 ±3.0
95%CIs [25.7, 26.4]) compared to the recommended item
(mean 24.8 ± 3.4 95%CIs [24.4, 25.2]) Wilcoxon Signed-
Ranks Test, T=9.9, p<.001. The final MMSE score was
based on the better score between the recommended and
alternate items.37 Using a cut-off score of <23, 51 (16.9%)
participants screened positive for cognitive impairment
and 251 (83.1%) screened negative. 
The mean MMSE score was 26.2 ±2.9, with scores
ranging from 15 to 30. Lower MMSE scores were
significantly associated with increased age groups (K=9.6,
p=.023), lower education groups (K=12.5, p=.002) and
race (whites scoring higher) (K=25.3, p<.001). Age
groups were 60-69, 70-79, 80-89, >90 years and education
groups were 8-11, 12, >12 years. Comparing the
performance of different participant age groups on the
recommended vs the alternate attention/concentration
items of the MMSE, no significant differences were noted
(K=2.8, p=.422 and K=3.6, p=.311 respectively). However,
participants with 8-11 years’ education scored
significantly lower on the recommended (K=22.3, p<.001)
compared to the alternate item (K=7.3, p=.03). Similarly,
there were significant differences for the race groups in
the recommended item score (blacks scoring lower)
(K=23.0, p<.001) but not for the alternate item score
(K=3.6, p=.315). The mean score for blacks on the
recommended item was 1.7±1.5 compared to a mean
score of 4.8±0.7 on the alternate item (W=2.6, p=.011).
Direct logistic regression was used to report the effect
of race, age and education together, and the relative
contribution of each of the variables to the MMSE
categories. The full model containing all the predictors
were statistically significant (X2 (n=302, 5) =19.8 p<.001),
indicating that the model was able to distinguish between
cases with and without cognitive impairment. It explained
between 6.4% (Cox and Snell R square) and 10.7%
(NagelKerke R Squared) of the variance in classification
of cognitive impairment, correctly classifying 82.8% of
cases. As shown in Table II, only education made a
statistically significant contribution to the model. The
odds ratio of 0.71 for years of education was less than
one, indicating that for every additional year of education,
respondents were 0.71 times less likely to be classified as
suffering from cognitive impairment as identified by the
MMSE. 
In considering the effect of these variables on
individual items, education levels significantly influenced
the performance on the following: geographical
orientation (K=8.1, p=.017), recommended (K=22.3,
p=.001), and alternate attention/concentration (K=7.3,
p=.026), repetition (K=7.3, p=.026) and construction
items (K=13.5, p=.001).
There were significant differences between the race
groups (with Black participants scoring consistently lower
than other race groups) on 3 orientation items (K=9.3,
p=.025; K=9.3, p=.025; K=16.3, p=.001), as well as on the
attention/concentration (K=23.0, p=.000), naming (K=10.7,
p=.014), repetition ’ (K=21.4, p=.001), comprehension of
verbal (K=17,0, p=.001), and written command (K=12.7,
p=.005) items. 
Gender accounted for significant differences in 2
orientation items (K=2.7, p=.006) and (K=2.1, p=.036),
the recommended (K=2.7, p=.007), and the alternate
attention/concentration items (K=2.5, p=.015). Females
performed better on all these items except for the
recommended attention/concentration item.
In comparing the screen positives on the MMSE
(n=51) with the screen negatives (n=251), there were
significant differences in the positive and negative screen
group for years of education, MMSE, SIS and GDS scores,
Table II: Logistic regression predicting likelihood of classification as dementia using the MMSE score
Step 1*
B se Wald df p-value Exp(B)
95% C I for EXP(B)
Lower Upper
Age .03 .02 1.50 1 .22 1.03 .98 1.07
Years of education -.35 .10 11.57 1 .001* .71 .58 .86
Race (White) 3.35 3 .34
Race (Asian) .48 .42 1.320 1 .25 1.61 .71 3.65
Race (Coloured) .03 .42 .01 1 .94 1.03 .46 2.33
Race (Black) 1.16 .77 2.26 1 .13 3.19 .71 14.43
Constant -.25 1.89 .02 1 .90 .78
* Significance set p<.05. Variable(s) entered on step 1: age, race, and years of education. B=un standardized coefficients; se=standard error; Wald=Wald
test; df-degrees of freedom; Cp-value= significance; Exp (B) = odd ratios and CI=confidence intervals
ORIGINAL Afr J Psychiatry 2013;16:445-455
African Journal of Psychiatry • November 2013 449
but there was no significant association between MMSE
screen positives and GDS positive categories (Table III). 
In addition to the full MMSE, the SIS was analysed to
determine its sensitivity and specificity to screen for cognitive
impairment. The SIS score was significantly affected by race
(K=8.2, p=.041) and age groups (K=7.8, p=.049) but not by
gender (U=-0.3, p=.806,) or education groups (K=1.1,
p=.578). Using the SIS with a cut of < 4, 114 (37.7%)
participants screened positive for cognitive impairment.
Testing whether the SIS categories could be used to predict
cognitive impairment as measured by the MMSE resulted in a
sensitivity of 82.3 %, 95% CIs[68.7%, 91.1%] and a specificity
of 71.3%, 95% CIs[65.2%, 76.7%]. 
Subjective Memory Complaint (SMC) and Subjective
Memory Rating Scale (SMRS)
Subjective memory complaints were reported by one
hundred and forty participants (46%) but its presence was not
significantly associated with race (X2=4.7, p=.193), gender
(X2=0.8, p=.438), age (U=1.8, p=.07) or education (U=0.8,
p=.426). There was no significant association between the
presence of SMCs and MMSE scores (U=1.2 p=.235). SMCs
were significantly associated with depression (X2=18.4,
p<.001).
Using the MMSE scores to assign caseness, the presence
of SMCs had a sensitivity of 54.6%, 95% CIs [44.2%, 64.7%]
and a specificity of 57.6%, 95% CIs [50.5%, 64.4%] in
identifying possible cognitive impairment cases. 
The SMRS was administered to 140 participants who
reported a SMC, with the mean SMRS score being 17.7, ±1.9,
and a range of 15-24. The distribution of scores was not
influenced by gender (U=0.9, p=.389) or educational level
(K=5.5, p=.07) but was significantly associated with race
(K=8.9, p=.03) and age group (K=14.7, p=.02). There was
no significant association between SMRS categories and
MMSE scores (U=0.6 p=.548). 
Using the recommended cut-off of >20 to determine
screen positives, 20 (14.3%) screened positive on the
SMRS and 120 (85.7%) screened negative. There was a
significant association between age, race and depression
(Table IV) and screen categories.
Using the MMSE scores to assign caseness, the SMRS
had a sensitivity of 17.0%, 95% CIs [8.5%, 30.3%] and
specificity of 87.4%, 95% CI [78.1%, 93.2%]. 
Deterioration Cognitive Observee (DECO)
Of the 207 participants (64.7%) who provided details of
eligible informants, 76 (36.7%) were contactable and were
able to complete a DECO. Of these, 20 (9.7%) completed
all 19 items on the DECO. This was due to two DECO items
consistently having high missing values. These were
writing letters (37, 48.7% completion rate) and reminding a
person of a conversation (39, 51.3% completion rate).
Adjusting for the denominator to take into consideration
missing items, made no difference to caseness, and the
decision was made to assign all missing data a score of
zero.
The average DECO score was 30.9 ± 5.8, ranging from
4 to 38. Using the recommended cut off score of <24
(maximum score=38), eight (10.5%) screened positive for
cognitive impairment. There were significant differences
between the screen positives and screen negatives for
gender and the DECO score (Table V).
Using the MMSE scores to assign caseness, the DECO
was found to have a sensitivity of 37.5%, 95% CI [6.3%,
64.2%] and specificity of 96.7%, 95% CI [87.5%, 99.4%].
Table III: Comparison of Participants with positive vs negative screen on MMSE
Item Screen positive MMSE Screen negative MMSE
<24 >24 Statistic P
N=51 (16.9 %) N=251 (83.1%)
Age 74.2 ± 7.6 73.4 ± 7.8 T=0.66 .51
Race Asian 13 (25.5%) 45 (17.9%) X2=4.3 .182
Black 3 (5.9%) 6 (2.4%)
Coloured 12 (23.5%) 55 (21.9%)
White 23 (45.1%) 145 (57.8%)
Gender Female 32 (62.7%) 187 (74.5%) X2=2.9 .086
Male 19 (37.3%) 64 (25.5%)
Years of education 9.4 ±1.7 10.6 ±2.2 T=3.6 <.001*
Depression (GDS positive >11) 20 (40%) 80 (31.9%) X2=1.2 .265
MMSE /30 21.0 ±2.2 27.2 ±1.7 U =11.4 <.001*
SIS score /6 3.2 ±1.5 4.9±0.9 U =8.0 <.001*
SIS positive <=4 42 (82.4%) 72 (28.75) X2=52.0 <.001*
Age and Years of Education were compared using Independent Samples T-Tests. MMSE, SIS scores were compared using Independent Samples Mann-
Whitney U Tests. Gender, Race, GDS and SIS categories were compared using Pearson Chi-square Tests. *Significance level set as p<.05.
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Discussion
The benefits of early identification of dementia, even in the
absence of disease-modifying pharmacological agents, are
well-recognised.4 MCI, while regarded as a pre-dementia
stage, has been shown to have a variable course and lends
itself to implementation of risk management if diagnosed
early.39 There is therefore a need for the early recognition of
cognitive impairment (dementia and MCI) at community and
primary care level for which validated and simple tools are
necessary. This study provided measures of prevalence of
cognitive impairment using different tools, assessed the
performance of a number of cognitive screening instruments
and quantified the degree to which race, age and education
level influenced their performance. It also highlighted the
challenges associated with screening. 
Prevalence estimates of cognitive impairment 
Using the different tools, the ‘prevalence’ of cognitive
impairment in this population was 16.9% using the MMSE and
ranged from 10.5% (DECO) to 46.3% (SMC). The tools also
had widely varying sensitivities (17%-82%) and specificities
(57.6%-96.7%) when compared with the MMSE.. These
discrepant figures suggest that the various instruments, while
measuring cognitive impairment, may have different
underlying constructs and hence may not be readily
comparable with each other. The detail of the performance of
each test is discussed below.
Performance of Tools
The first set of screening tools was objective measures of
cognitive impairment. The MMSE is the most widely used
Table IV: Comparison of Participants with positive vs negative screen on SMRS
Item Screen positive SMRS Screen negative 
>20 <19 Test P
N=20 (14.3%) SMRS N=120 (85.7%)
Age 69.3 ±6.5 75.2±7.7 T=3.3 .001*
Race Asian 9 (45%) 15 (12.5%) X2=14.1 .002*
Black 1 (5%) 5 (4.2%)
Coloured 6 (30%) 31 (25.8%)
White 4 (20%) 69(57.5%)
Gender Female 15 (75%) 90 (75%) X2=0.2 .681
Male 5 (25%) 30 (25%)
Years of education 10.6 ±2,6 10.2 ±1.9 U=0.3 .753
Depression (GDS) 14(70%) 50(41.7%) X2=5.5 .019*
SMRS score 21.2±1.3 17.1±1.2 U=7.3 <.001*
Age was compared using Independent Samples T-Tests. Years of Education, SMRS and MMSE were compared using Independent Samples Mann-Whitney
U Tests. Gender and race were compared using Pearson Chi-square Tests.*Significance level set as p< .05.
Table V: Comparison of Participants with positive vs negative screen on DECO
Item Screen positive Screen negative Statistic P
=<24/38 >24/38
N=8(10.5%) N=68 (89.5%)
Age 75.3 ±8.5 70.5±6.4 T=1.9 .06
Race Asian 1 (13%) A 18 (26.5%) X2=2.4 .338
Coloured 4 (50%) C 16 (23.5%)
White 3(37%) W 34(50%)
Gender Female 2 (25%) 43 (63.2%) X2=4.3 .06*
Male 6 (75%) 25 (36.7%)
Years of education 10.6 ±3.3 9.8 ±1.6 U=0.3 .807
DECO score 16.6 ±5.9 32.5 ±2.6 U=4.6 <.001*
Age was compared using Independent Samples T-Tests. Years of Education, and DECO were compared using Independent Samples Mann-Whitney U
Tests. Gender and race were compared using Pearson Chi-square Tests. *Significance level set as p< .05.
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cognitive screening test35 and may remain the best screening
tool for primary care clinicians to rule in or rule out a
diagnosis of dementia.40 In our study, the MMSE identified 51
while the SIS identified twice the number (114) of participants
with possible cognitive impairment. Compared with the
MMSE, the SIS showed good sensitivity and specificity
suggesting that it may be a useful screening tool as an
alternative to the MMSE locally. This confirms findings from an
international study where a good correlation was
demonstrated between the MMSE and SIS in a community-
based sample.32 Subsequent studies have been divided on its
efficacy with one study yielding lower sensitivities41 and
another finding it a reliable and effective tool for dementia but
not MCI detection.42 In view of the large difference in case
identification between the MMSE and the SIS, the relative
merits of using the MMSE or the SIS locally is best
determined once the validity of the MMSE is established
against the gold standard of a clinical diagnosis of cognitive
impairment.
The second set of screening tools assessed subjective
cognitive impairments. Subjective knowledge and awareness
of memory deficits (meta-memory)38 are frequently reported
by the elderly. In our study a prevalence of 46% of SMC was
found. A UK study, using a primary health-care sample,
reported a 46.5% prevalence of any cognitive complaint in the
elderly, with an increase in prevalence occurring with
increasing age and among females.43 Conversely, a recent
study reports the prevalence of a lack of awareness of
memory deficits ranging from 63% to 81% across three
LAMICs and that absence of awareness is associated with
depression, dementia severity, socio-economic status and
education in different sites.44 In community settings, 20% of
individuals with SMC are likely to have dementia and 30%
MCI.38 Establishing the presence of SMCs may prove useful
as they have been associated with characteristic neuro-
imaging changes in the temporal and hippocampal regions45,
and may represent a degree of cognitive impairment that is
not currently measurable by objective tests.46 SMCs may
therefore represent a simple and cost-effective way of
identifying underlying impairment which would obviate the
need for validated tools and trained administration staff.
However, despite SMCs being a diagnostic criterion for
MCI10, there is a lack of consistency in how SMCs are
defined.47 The construct underlying subjective impairment
may be influenced by cultural variables and may account for
the large variation in MCI prevalence across LAMIC.13 The
implication of the lack of a consistent definition of subjective
memory impairment is illustrated in our findings where two
subjective measures yielded markedly different results.
In our study, 46.3%of participants reported the presence
of a subjective memory complaint (SMC) and of these the
SMRS identified 14.3% as being possibly cognitively
impaired. While the discrepancy could be attributed to the
SMRS being a more specific and detailed measure of
subjective cognitive impairment, this is not supported by the
differences in sensitivities of the two measures as compared
against the MMSE. 
The third set of tools included the informant questionnaire,
the DECO. Informant assessments have several advantages
over patient administered screening tools. Direct information
about a decline in daily functioning can be elicited from those
who know the patient well.30 While brief cognitive screening
tests, short neuro-psychological batteries and informant
questionnaires have comparable discriminability, informant
observations are less influenced by the educational levels of
subjects being screened and retained discriminability in mild
dementia.48 Informant questionnaire may therefore prove
valuable for local community screening where informants
may be more readily available than in residential facilities;
they may also have utility in settings where low educational
levels of the elderly may limit the use of the MMSE.
Of the 76 respondents on the DECO, 73.7% were unable to
respond to all 19 items. Informants were unable to respond to
letter writing and remembering a conversation items which
may be similar to other studies which identified the items
pertaining to household appliances, handling of money and
writing as necessitating replacement with culturally suitable
alternatives29 to improve the potential of the DECO to be a
‘useful instrument to diagnose dementia cross-culturally in
SA’.30 Using the MMSE as a gold standard, our study revealed
a much lower sensitivity than that obtained in a pilot study in a
small cross-cultural South African sample. The DECO in the
latter study had a sensitivity of 79% and a specificity of 90%, a
good correlation with the MMSE (r=0.625; p<0.01) and
validity for the diagnosis of mild and moderate dementia.30
The unavailability of informants for 75% of the participants
in the study, including none for black participants, is much
higher than that reported in the literature (viz. 19%49 and
5%50) and limits proper evaluation of the validity of the DECO
and the generalizability of our findings. However, the
substantial lack of informants raises the question of the utility
of this tool in a residential setting. Social support in the elderly
has clinical implications, identifying this group as being at risk
for cognitive disorders. Studies confirm the role of social
integration and the quality and quantity of social relationships
in maintaining cognitive vitality51, reducing the risk for AD52,53
decreasing psychiatric morbidity54,55, influencing physical
health55 mortality risk55,56, predicting quality of life57, and
reducing the rate of memory decline58 in the elderly. On the
basis of the implied low levels of regular family contact,
subsequent low response rate and low sensitivity, the utility of
the DECO as a screening instrument suitable for use in this
population appears to be limited.
Influence of demographic variables and depression
Race, age and years of education were shown to affect the
performance of the measures used in our study. 
Race: There was a significant association between race and
the SIS, SMRS and specific items of the MMSE. The
recommended and alternate attention/concentration items ’
are not equivalent37 and this was evidenced in the poorer
performance of participants of different races on the
recommended item and suggesting that the alternate item
should be preferred in this heterogeneous sample . However,
there were two issues to consider here namely, there were
only 9 black participants in the study and there were
significant differences between race groups in terms of age
and years of education. Replication of these results in a larger
sample will confirm the validity of these associations.
The differences between race groups for individual items
on the MMSE largely disappeared with the use of the better
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score between the 2 attention/concentration items. This
suggests that, in the local population, the use of the
recommended attention/concentration item of the MMSE does
not demonstrate cross-cultural equivalence59, and may need
to be adapted according to the cultural, demographic and
educational profile of the population being screened. Age,
educational level, ethnicity and language of administration
have been shown to influence frequency of errors and scores
on the MMSE.60 Attempts have been made in many countries
to translate and adapt the MMSE for local use.20,61 The relative
difficulty of certain items has been shown to vary between
ethnic groups within the United States24 and a study
comparing UK and USA dementia populations suggested that
the MMSE items may not be dynamically equivalent even
within Western race groups.25 Establishing separate test
norms for different racial groups may help to improve the
accuracy of tools. Alternatively, direct and more meaningful
and predictive variables that underlie test performance
across cultural groups may serve to increase the validity of
the instruments used to diagnose dementia.62
Age: Although age is a risk factor for dementia, dementia is
not an inevitable consequence of ageing, and its effects
cannot be dismissed as representing psychometric bias. In
keeping with previous studies that showed a decrease in
MMSE scores as age increases37, scores in our sample were
significantly lower in older participants (p=.023) although the
mean age of those screening positive was not significantly
greater than those screening negative (p=.74). There exists a
complex relationship between MMSE scores, age and
educational level which may have implications for the cut-off
score.37 Age effects were also evident with the SIS (p=.049)
and SMRS scores where screen positives were significantly
younger (p=.001); however, no age effect was evident with the
SMC measurement. This could possibly be explained on the
basis of younger participants retaining awareness of the
details of their subjective cognitive status (measures on the
SMRS) while the simpler measure of SMC was not
confounded by age-effects. 
Education: Education has been found to be the most
important non-biological correlate of cognitive
performance63-65 and the ‘cultural variable,’ which includes
education and urbanization, making it the largest contributor
to performance variance on psychometric tests66,67 more so
than ethnicity or the traditional variables of age, sex and
socio-economic status.68 MMSE scores were confounded by
the level of education (p=.02) of participants in this study. A
previous local study found no correlation between education
and MMSE scores30, which could be attributed to the
adaptations (especially on the educationally biased items)
made to the MMSE administered in that study. Education
levels significantly influenced the performance on individual
MMSE items which confirms earlier research on the
differential item performance attributable to education, race,
ethnicity and language, and its use in educationally
disadvantaged populations has been questioned.69 Given the
significantly poorer performance of participants with lower
education levels on the recommended attention/concentration
item the alternate item would preferred for local MMSE
administration. Performance on the SIS was not significantly
associated with education (p=.578) suggesting that this
subset of MMSE items are less influenced by education
effects and that it could be a useful alternative to the MMSE
locally. 
General population studies have consistently
demonstrated that a lower educational level is associated with
an increased probability of scoring below the recommended
MMSE cut point70, and literacy is suggested to be a more
sensitive proxy for cognitive reserve than years of
education.71 Although the MMSE (with modifications) has
been used in illiterate populations72, there are reports of
numerous challenges20,72 due to the complex relationship that
exists between literacy and dementia risk and prevalence.62
As there is a higher prevalence of illiteracy among the elderly
in LAMIC73 these challenges may be compounded. 
Discrepancies in both the quantity and quality of
education62 between racial groups, especially among the
elderly in South Africa who would have been exposed to
education during the apartheid era, will impact on test
performance. Among South Africans aged 60 years and older,
two-thirds of blacks and Asians and half of coloureds had less
than five years of education and rural blacks had a literacy
rate of 29%.74 In our study, each year of formal education was
found to reduce the likelihood of screening positive on the
MMSE by a factor of 0.71 thus warranting caution in its
widespread local use without further evaluation and possible
adaptation. The finding also highlights the important role of
education and cognitive stimulation in increasing brain
reserve capacity and protecting against disease
manifestation. The SMCs (p=.426) and SMRS scores (p=.07)
were not significantly influenced by the level of education of
participants and assessments of subjective memory may offer
a possible solution to the challenges posed by educational
influences on test performance.
Cognitive impairment has been documented in geriatric
depression75,76 and the frequent co-existence of dementia and
depression suggests that the two conditions share a complex
association with each other.77 Depression may be an early
manifestation of dementia78 or a risk factor for its
development.79,80 However, in our study, a screen positive on
the MMSE was not significantly associated with depression
(p=.109). SMCs have also been shown to be associated with
depression81,82 and this was evident in our study where the
presences of SMCs(p<.001) as well as screen positives on the
SMRS (p=.019) were found to be significantly associated with
depression. The utility of subjective measures of cognitive
impairment should therefore always be assessed in
conjunction with mood disorders in the elderly.
Challenges of screening 
The study faced two challenges in conducting screening in
this population, one being the refusal of residents to
participate, and the other being the low number of
contactable informants on which to conduct the DECO. Nearly
a third of the local residents refused to participate in the
study; this is contrary to the view that the elderly in
developing countries are more likely to co-operate in studies
due to the attraction of ‘free’ health care and other incentives
for participation.20 In a recent comparison between the
elderly in the US and the UK, 39.4% and 32.1% of respondents
respectively found screening to be unacceptable.15 Refusal
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rates in high income countries vary from 19%83 to 50%84, and
among those agreeing to be screened, 47.7% of those
screening positive refused further assessments, perceiving
themselves to have no cognitive deficits; older blacks were
more likely than whites to refuse screening.84 Due to the low
numbers of blacks in our sample, racial differences in
acceptance of screening is yet to be determined locally. A
lack of awareness of dementia and possible anxiety about
being diagnosed may have contributed to the low level of
acceptance in our sample. However, it is important, if
screening initiatives are to be successful, that reasons for
refusal are formally identified so that they can be addressed.
A second challenge was the low numbers of contactable
informants (N=76; 25.2%), which posed a significant
constraint on both screening and diagnostic activities, as the
information provided by collateral sources are invaluable for
the diagnosis and management of cognitive disorders. In a
local study among a Xhosa-speaking black sample, a 69.4%
agreement was reported between clinicians’ and relatives’
perceptions of normal and abnormal cognition85, highlighting
the importance of caregivers’ observations about cognitive
decline when making an assessment of cognitive decline. 
Limitations 
This study had a number of limitations which affects the
generalizability of the findings. Firstly, the sample represented
an urban setting within a non-governmental organization in
KwaZulu-Natal. Secondly, the restricted inclusion criteria may
have precluded participation of the elderly with severe
dementia. Thirdly, there was a high participant refusal rate.
Fourthly, the majority of the sample was white. Fourthly, the
validity of the various instruments is better measured against
the gold standard of a clinical diagnosis of cognitive
impairment. Lastly, the low number of respondents on the
DECO, including the lack of black respondents, limits the
generalizability of its performance. 
Recommendations
The study highlights the need for further investigation in the
use of screening measures in other populations, using larger
sample sizes and conducting household surveys among the
elderly who are cared for by family-members. This will be
especially important since collateral information may be more
easily obtained from their care givers. In view of the widely
discrepant performance between the attention/concentration
items it is recommended that the alternate item be used when
administering the MMSE locally.
Conclusion
Despite the identified limitations, the study is the first South
African study to estimate the prevalence of cognitive
impairment in this setting and to evaluate the performance of
different types of screening instruments for cognitive
impairment among the diverse race groups in the country.
The performance of the screening tools in this study confirms
the concerns raised about the validity of instruments
developed for culturally homogeneous Western populations
that are used in populations that are demographically and
educationally heterogeneous.30 In addition, the estimated
burden of cognitive impairment is significant and highlights
the need for increased awareness in a ‘super-aging society 86
of the importance of screening and the need for an
appropriate, valid screening tool for health workers in clinical
settings and for cross-cultural research.21
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